| James Jogerst |
James Jogerst is currently the Chief Business Officer at Rubius Therapeutics, Inc. Prior to this, he worked as the Vice President-Corporate Development at Adare Pharma Solutions, Inc. from 2015 to 2017. Jogerst holds an MBA from Pepperdine University and an undergraduate degree from the University of North Texas. |
| Lori Murray |
Lori Murray is currently the Chief Corporate Affairs Officer at Rubius Therapeutics, Inc. She previously worked at Onyx Pharmaceuticals, Inc. as the Head-Media Relations from 2009 to 2015. Ms. Murray completed her undergraduate degree at the University of California, Davis and holds an MBA from the University of San Francisco. |
| Craig R. Jalbert |
Craig R. Jalbert currently works at Bellerophon Therapeutics, Inc., as President, CEO, CFO, Secretary & Treasurer from 2023, Axcella Health, Inc., as President, CEO, Secretary, Treasurer & Director, Evelo Biosciences, Inc., as President, CEO, CFO, Secretary & Director from 2023, Aptinyx, Inc., as President, CEO, CFO, Secretary, Treasurer & CAO from 2023, Oncorus, Inc., as President, CEO, CFO, Secretary & Treasurer from 2023, Better Therapeutics, Inc., as President, CEO, Secretary & Treasurer from 2024, CohBar, Inc., as Director from 2023, Fetco Home Decor, Inc., as President, Secretary, Treasurer. & Director, Seaside Therapeutics LLC, as President & Director, Rubius Therapeutics, Inc., as President, Secretary, Treasurer & Director from 2023, Mitralign, Inc., as President, Secretary, Treasurer & Director, and Verdolino & Lowey PC, as Principal from 1987. Mr. Jalbert also formerly worked at Agritech Worldwide, Inc., as Chief Executive Officer, CFO & Director, MZT Holdings, Inc., as President, CEO, CFO, Secretary, Treasurer & CAO from 2010 to 2012, Cambridge Heart, Inc., as President, Secretary, Treasurer & Director, Dendreon Corp., as President, Secretary, Treasurer & Director, SIONEX Corp., as President, Secretary, Treasurer & Director, CompuCyte Corp., as President, Secretary, Treasurer & Director, Matritech, Inc., as President & Treasurer, and Ibis Technology Corp., as President, Secretary & Treasurer from 2009 to 2012. |
| Robert S. Langer |
Robert S. Langer is the founder of Acusphere, Inc. (1993), Pulmatrix Operating Co., Inc. (2003), Arsenal Medical, Inc. (2005), InVivo Therapeutics Corp. (2001), Combinent BioMedical Systems, Inc. (2000), Invivo Therapeutics Holdings Corp. (2005), Tarveda Therapeutics, Inc. (2011), Tissium SA (2013), Eagle Biologics, Inc. (2013), Pulmatrix, Inc. (2015), PixarBio Corp. (2014), NextRNA Therapeutics, Inc. (2021), Momenta Pharmaceuticals, Inc. (2001), Pervasis Therapeutics, Inc. (2004), DNIB Unwind, Inc. (2006), TARIS BioMedical LLC (2008), YourBio Health, Inc. (2008), Selecta Biosciences, Inc. (2007), KALA BIO, Inc. (2009), SQZ Biotechnologies Co. (2013), Living Proof, Inc. (2004), Puretech Health LLC (2000), Microchips Biotech, Inc. (1999), T2 Biosystems, Inc. (2006), Lyra Therapeutics, Inc. (2006), XTuit Pharmaceuticals, Inc. (2011), PureTech Health Plc (2015), Lyndra Therapeutics, Inc. (2015), Sigilon Therapeutics, Inc. (2015), Verseau Therapeutics, Inc. (2017), Frequency Therapeutics, Inc. (2014), Seer, Inc. (California) (2017), Moderna, Inc. (2010). Dr. Langer is also the founder of TransForm Pharmaceuticals, Inc., Sontra Medical, Inc., Semprus BioSciences Corp., Olivo Laboratories LLC, Suono Bio, Inc., Alivio Therapeutics, Inc., Celero Systems, Inc., Syntis Bio, Inc... Dr. Langer's current job(s) include Director at Micell Technologies, Inc., Director at Abpro Corp., Director at Humacyte Global, Inc., Director at StemBioSys, Inc., Director at Cornell University, Director at Whitehead Institute for Biomedical Research, Director at Noveome Biotherapeutics, Inc., Director at Golub & Co. LLC, Director at Abpro Bio Co., Ltd., Director at CHS Pharma, Inc., Director at Entrega, Inc., Director at TARA Biosystems, Inc., Director at Aris Pharmaceuticals, Inc., Director at Luminopia, Inc., Director at EpiBone, Inc., Director at Glympse Bio, Inc., Director at LikeMinds, Inc. (Mass. |
